We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

156 hedge funds and large institutions have $181M invested in BioDelivery Sciences International, Inc. in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 44 increasing their positions, 52 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

406% more call options, than puts

Call options by funds: $5.93M | Put options by funds: $1.17M

27% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 22

3% more funds holding

Funds holding: 151156 (+5)

15% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 52

18% less capital invested

Capital invested by funds: $221M → $181M (-$40.1M)

Holders
156
Holders Change
+5
Holders Change %
+3.31%
% of All Funds
2.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
28
Increased
44
Reduced
52
Closed
22
Calls
$5.93M
Puts
$1.17M
Net Calls
+$4.75M
Net Calls Change
+$2.37M
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.47M +$283K +83,986 +22%
William Blair & Company
27
William Blair & Company
Illinois
$1.44M -$804K -239,060 -34%
Two Sigma Investments
28
Two Sigma Investments
New York
$1.41M +$163K +48,400 +12%
Goldman Sachs
29
Goldman Sachs
New York
$1.25M -$489K -145,340 -27%
JMPWA
30
JP Morgan Private Wealth Advisors
California
$1.23M -$15K -4,453 -1%
Simplex Trading
31
Simplex Trading
Illinois
$1.09M +$1.19M +352,537 New
BFM
32
Boothbay Fund Management
New York
$1.06M +$810K +240,680 +239%
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$1.02M +$659K +195,875 +146%
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$1M +$822K +244,207 +307%
Schroder Investment Management Group
35
Schroder Investment Management Group
United Kingdom
$985K -$22.5K -6,685 -2%
Wells Fargo
36
Wells Fargo
California
$962K -$1.22M -363,142 -54%
Renaissance Technologies
37
Renaissance Technologies
New York
$944K +$415K +123,300 +68%
State Board of Administration of Florida Retirement System
38
State Board of Administration of Florida Retirement System
Florida
$942K +$696K +206,734 +213%
Allspring Global Investments
39
Allspring Global Investments
North Carolina
$829K +$900K +267,470 New
Victory Capital Management
40
Victory Capital Management
Texas
$789K +$318K +94,502 +59%
Jacobs Levy Equity Management
41
Jacobs Levy Equity Management
New Jersey
$783K +$850K +252,584 New
Morgan Stanley
42
Morgan Stanley
New York
$768K +$126K +37,484 +18%
Bank of America
43
Bank of America
North Carolina
$739K -$94.4K -28,061 -11%
PAM
44
Panagora Asset Management
Massachusetts
$714K +$629 +187 +0.1%
American Century Companies
45
American Century Companies
Missouri
$679K +$256K +76,209 +53%
ECM
46
EMC Capital Management
Texas
$647K
BCI
47
Brinker Capital Investments
Pennsylvania
$587K -$304K -90,426 -32%
CAM
48
ClariVest Asset Management
California
$584K -$7.83K -2,327 -1%
Swiss National Bank
49
Swiss National Bank
Switzerland
$574K
Barclays
50
Barclays
United Kingdom
$547K +$35K +10,392 +6%

BDSI Hedge Fund Activity: Q4 2021 in Review

156 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q4 2021, worth a combined $181M — down 18% from $221M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new BDSI positions and 22 closed out — a net gain of 6 holders — while 44 added to existing stakes and 52 trimmed.

The largest buyer was Rubric Capital Management (New York), opening a new position worth an estimated $5.88M. The largest seller was Deerfield Management, cutting an estimated $30.8M.

  • 156 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q4 2021, up from 151 in Q3 2021.
  • Funds reported $181M of BioDelivery Sciences International, Inc. stock for Q4 2021, down 18% quarter-over-quarter.
  • 28 funds opened new BioDelivery Sciences International, Inc. positions in Q4 2021 and 22 closed out, a net change of +6 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q4 2021 was Rubric Capital Management (New York), an estimated $5.88M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q4 2021 was Deerfield Management, an estimated $30.8M sold.

Based on aggregated 13F filings for Q4 2021.